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Abstract
The choice of treatment in gastric lymphoma is stage dependent. Endoscopic ultrasound (EUS) is a very accurate technique
to assess T- and N-staging of primary gastric lymphoma. Two cases of high-grade gastric non-Hodgkin’s lymphoma are
documented with videos of upper endoscopy and EUS. The technique for an appropriate staging of the disease with EUS is
demonstrated. This article is part of an expert video encyclopedia.
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Techniques
Esophagogastroduodenoscopy; endoscopic ultrasound (EUS);
and contrast harmonic EUS.
Materials
• Gastroscope: GIF-Q165; Olympus, Tokyo, Japan.
• Echoendoscope: GF-UE160; Olympus, Tokyo, Japan.
• Ultrasound unit: Alfa 10; Aloka, Tokyo, Japan.
• Contrast agent: SonoVue; Bracco, Amsterdam, The
Netherlands.
Key Learning Points
The gastrointestinal tract is the most commonly involved extra-
nodal site of non-Hodgkin’s lymphoma (NHL), and the stom-
ach is the most common site. The stomach can harbor a primary
NHL or be involved secondarily by a disseminated nodal dis-
ease. Considering the special properties of the digestive tract,
Isaacson et al.1 introduced the mucosa-associated lymphoid tis-
sue (MALT) concept, classifying primary gastric lymphoma as a
distinct entity with peculiar histological and biological features.
In the stomach, tumoral involvement can often be multi-
focal.2 From the mucosa, MALT lymphoma gradually inﬁl-
trates the underlying submucosa, muscularis propria, and
serosa; simultaneously, malignant cells can reach the regional
lymph nodes and other gastrointestinal tracts or the spleen.
Moreover, low-grade MALT lymphomas can evolve in high-
grade lymphomas, which have a more aggressive histological
and clinical behavior.
Although the stomach is the most common intestinal site
of MALT lymphoma, localizations to the duodenum, small
and large bowel, esophagus, rectum, larynx, and liver have
been reported.3–6
EUS has been demonstrated to be accurate for the differ-
ential diagnosis of large gastric folds. Gastric lymphoma,
linitis plastica, Menetrier’s disease, inﬂammatory conditions,
and gastric varices account for the most common etiologies
that can be accurately identiﬁed by EUS.7
EUS is very accurate for the diagnosis and staging of gastric
MALT lymphoma, which is the most important cause of large
gastric folds.8
The impact of EUS on clinical outcome of these patients is
consistent, as it can predict MALT remission after the simple
eradication therapy of Helicobacter pylori.9–10 In fact, early stage
disease inﬁltrating only the mucosa and/or submucosa, with
no involvement of lymph nodes, shows up to 80% response
rate. More aggressive therapies, such as chemotherapy and
surgery, can now be avoided in the majority of patients af-
fected from low-grade MALT lymphoma.
However, chemotherapy is considered as the treatment of
choice in patients with either high-grade lymphoma, advanced
disease, or no response to antibiotic regimens.11
It should be kept in mind that EUS is an operator-
dependent technique. Suboptimal interobserver agreement
has been reported in the staging of gastric lymphoma,12 as
well as with all the other EUS indications described in the
guidelines of the American Society of Gastrointestinal En-
doscopy.13 As a consequence, it is our duty to emphasize that
extensive operators’ experience and careful examination tech-
nique are always warranted to maintain the high levels of
accuracy reported in the literature.
Tips and Tricks
• EUS is the most accurate imaging modality for the staging
of gastric lymphoma.
• EUS can guide the therapeutic choice according to stage.
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• EUS may also be useful in the follow-up to assess response
to therapy and detect early relapse.
• Radial echoendoscopes are more suitable than the linear
ones for a complete imaging of the gastric wall.
• To obtain an accurate staging, the stomach should be
completely ﬁlled with water and debris, and mucus com-
pletely aspirated.
• Intravenous injection of antispasmodics improves relax-
ation of the gastric wall, thereby allowing an adequate as-
sessment of the layers to determine the T-stage.
Scripted Voiceover
Time
(min:sec)
Voiceover text
00:01 In this 67-year-old man, EGD reveals a large ulcerated
mass originating from the anterior face of the antrum
and involving the lesser curvature. Histology is
consistent with high grade B cell gastric lymphoma.
00:34 With retroﬂexion it is appreciated that gastric body and
fundus are regular. Endoscopic ultrasound (EUS) is
then performed for staging.
00:47 Adequate visualization of the oropharynx should be
obtained to ensure a safe intubation of the
esophagus with the echoendoscope. Passage
through the esophagus is done in a semi-blind
fashion due to the oblique endoscopic optic.
01:08 In the stomach, full endoscopic view is achieved
allowing proper orientation and positioning of the
echoendoscope in relation to the lesion of interest.
01:20 Water ﬁlling of the gastric lumen is essential to obtain
a good coupling of the ultrasound waves with the
gastric layers. Intravenous injection of Buscopan or
glucagon is also helpful to obtain relaxation of the
gastric wall. Moreover, meticulous aspiration of all
residual air pockets and mucus are essential for
proper ultrasound imaging. Inadequate distention of
the gastric wall and/or incomplete removal of the
gastric content may hamper a correct staging of the
tumor.
02:14 Once water ﬁlling has been completed, EUS imaging
begins in front of the pylorus.
02:21 EUS is performed with an electronic radial scanning
echoendoscope. The lesion is seen at the 9 o’clock
position as a hypoechoic mass inﬁltrating the gastric
wall; the layers are disrupted as typical of lymphoma.
The so called transition zone (i.e., the shift from
normal to abnormal wall) must be carefully evaluated
on both sides of the lesion to obtain an accurate T
staging. It is noticed that the lesion has inﬁltrated the
second and third layer (mucosa and submucosa) and
has extended into the fourth layer (muscularis
propria). The ﬁfth layer (serosa) is still preserved.
These features are compatible with a T2 stage gastric
lymphoma.
03:27 As gastric lymphoma often presents patchy
distribution, the exploration must be completed up to
the cardia. For proper visualization of the layers,
which are normal in this case, the transducer should
be kept in the center of the lumen while withdrawing
the echoendoscope.
03:55 N staging is subsequently performed. For this purpose,
scanning is initiated from the second portion of the
duodenum to search for perivisceral and perihepatic
lymph nodes. In this case, no lymph nodes are
visible. Normal pancreatic parenchyma, common bile
duct and portal vein are shown.
04:27 The procedure is completed with transgastric
scanning. The image is demagniﬁed to allow deeper
investigation of the perivisceral structures and
organs. In this case, no lymph nodes are visible.
Normal left hepatic lobe, spleen, pancreatic
parenchyma, and celiac trunk are shown. These
ﬁndings are compatible with an N0 stage gastric
lymphoma.
05:11 At the end of the procedure all the water is aspirated
from the stomach for the sake of the patient’s safety
and comfort.
05:23 In this 58-year-old woman, EGD reveals two large
vegetating lesions in the gastric body. Histology was
consistent with high grade B cell gastric lymphoma.
EUS is then performed for staging using an
electronic radial scanning echoendoscope. The same
technique as before is used to accomplish water
ﬁlling of the lumen and gastric distention.
06:05 The lesions extend over two thirds of the gastric
circumference. Upon evaluation of the transition
zone it is appreciated that the gastric wall is
inﬁltrated up to the ﬁfth layer (serosa). The latter is
disrupted due to tumoral invasion of the perigastric
fat, which is seen as pseudopodia. Care is taken to
keep the transducer in the center of the lumen to
allow appropriate orthogonal visualization of the
entire gastric wall, avoiding incorrect staging that
can occur with oblique scanning through the
neoplastic areas.
07:12 At ﬁrst sight no clear resection margin is appreciated
between the mass and the left lobe of the liver. Close
inspection and tissue harmonics allow an optimal
discrimination of the layers and tissues with different
impedance, revealing that the tumor is contiguous to
the liver but is not inﬁltrating into the parenchyma.
As a result T4 disease is ruled out.
07:51 Transduodenal scanning fails to reveal any perivisceral
lymph node.
08:01 However, transgastric scanning at the level of the
antrum shows a large hypoechoic lymph node
outside the greater curvature. This is likely
attributable to perigastric extension of the
lymphoma. Moreover, multiple small hypoechoic
lymph nodes are also visible outside the gastric wall
at the 10 o’clock position, nearby the outer margin of
the largest lesion. Perigastric tumoral invasion
appears in close proximity to the lymph nodes. Slight
back and forth movements of the echoendoscope
allow careful exploration of the whole area and are
essential to assess the TN staging correctly. Overall,
these ﬁndings are compatible with a T3 N3 stage
gastric lymphoma.
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09:11 Withdrawal of the echoendoscope proximal to the
lesions shows additional lymph nodes with
pathologic aspect near the liver hilum.
09:24 As a note of interest, contrast harmonic EUS after
intravenous injection of Sonovue is shown. Gastric
lymphoma appears diffusely hyperenhanced with a
homogeneous pattern. This behavior might prove
useful in evaluating the extension of the disease for
staging purposes. This is an off-label use of Sonovue
and further research is warranted to establish the role
of contrast harmonic EUS in gastric lymphoma staging.
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